European Leukemia Trial Registry
Trial: PANOBEST

More Details
Scientific Title Phase I/II study with oral panobinostat maintenance therapy following allogeneic stem cell transplantation in patients with high risk MDS or AML (PANOBEST)
Short Title PANOBEST
Trialgroup NN
Type of Trial multicentric, open-label
Disease Stem cell transplantation(SCT) AML
Acute myeloid leukemia(AML) Stem cell transplantation
Stem cell transplantation(SCT) MDS
Myelodysplastic Syndrome(MDS) Stem cell transplantation
Age >= 18 years
Status Follow up
Start of Recruitment 01.01.2011
Leader Bug, PD Dr. med., Gesine
Contactperson

Study Centre
Wolf, Andrea
Tel: +49 (0)69 63016429
Fax: +49 (0)69 63017463
Email: andrea.wolf@em.uni-frankfurt.de

Study Centre
Gökbuget, Dr. med., Nicola
Tel: +49 (0)69 6301-6366
Fax: +49 (0)69 6301- 7463
Email: goekbuget@em.uni-frankfurt.de

Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
Diagnostics

FACS-Analysis
Stammzell-Labor der Klinik für Kinderheilkunde III

Chimaerism
Stammzell-Labor der Klinik für Kinderheilkunde III

created 24.11.2010 Johannes Kraus
changed 28.11.2018 Zenawit Krüger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org